528 related articles for article (PubMed ID: 24881112)
1. Pharmaceutical compounding or pharmaceutical manufacturing? A regulatory perspective.
Timko RJ; Crooker PE
Int J Pharm Compd; 2014; 18(2):101-11. PubMed ID: 24881112
[TBL] [Abstract][Full Text] [Related]
2. Applying Quality by Design Concepts to Pharmacy Compounding.
Timko RJ
Int J Pharm Compd; 2015; 19(6):453-63. PubMed ID: 26891559
[TBL] [Abstract][Full Text] [Related]
3. Regulating Compounding Pharmacies.
Noble A
NCSL Legisbrief; 2016 Nov; 24(42):1-2. PubMed ID: 27911513
[No Abstract] [Full Text] [Related]
4. Potential risks of pharmacy compounding.
Gudeman J; Jozwiakowski M; Chollet J; Randell M
Drugs R D; 2013 Mar; 13(1):1-8. PubMed ID: 23526368
[TBL] [Abstract][Full Text] [Related]
5. Compounding pharmacies: before and after an inspection.
Kulkarni D; Ricketts S
Int J Pharm Compd; 2013; 17(5):358-62. PubMed ID: 24459779
[TBL] [Abstract][Full Text] [Related]
6. Compounding pharmacy conundrum: "we cannot live without them but we cannot live with them" according to the present paradigm.
Guharoy R; Noviasky J; Haydar Z; Fakih MG; Hartman C
Chest; 2013 Apr; 143(4):896-900. PubMed ID: 23412546
[TBL] [Abstract][Full Text] [Related]
7. How gaps in regulation of compounding pharmacy set the stage for a multistate fungal meningitis outbreak.
Teshome BF; Reveles KR; Lee GC; Ryan L; Frei CR
J Am Pharm Assoc (2003); 2014; 54(4):441-5. PubMed ID: 25063265
[TBL] [Abstract][Full Text] [Related]
8. 2013 State Compounding Legislation Tracker.
Miller DG
Int J Pharm Compd; 2013; 17(5):375-8. PubMed ID: 24459782
[No Abstract] [Full Text] [Related]
9. U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies.
Yoch D
Int J Pharm Compd; 2017; 21(2):95-102. PubMed ID: 28346203
[TBL] [Abstract][Full Text] [Related]
10. U.S. Food and Drug Administration requests for input on HR 3204 enactment: the Drug Quality and Security Act of 2013.
Miller DG
Int J Pharm Compd; 2014; 18(1):35-6. PubMed ID: 24881338
[No Abstract] [Full Text] [Related]
11. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.
Hyde TD
Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341
[TBL] [Abstract][Full Text] [Related]
12. Quality Assurance and Quality Control, Part 2.
Akers MJ
Int J Pharm Compd; 2015; 19(3):215-21. PubMed ID: 26714362
[TBL] [Abstract][Full Text] [Related]
13. The standardization of nonsterile compounding: a study in quality control and assessment for hormone compounding.
Wiley TS; Odegard RD; Raden J; Haraldsen JT
Int J Pharm Compd; 2014; 18(2):162-8. PubMed ID: 24881121
[TBL] [Abstract][Full Text] [Related]
14. Compounding interest: a tragedy caused by contaminated steroids turned the spotlight on compounding pharmacies.
Hinkley KN
State Legis; 2013 Jun; 39(6):22-3. PubMed ID: 23805443
[No Abstract] [Full Text] [Related]
15. Regulators faulted for inadequate compounding pharmacy oversight.
Traynor K
Am J Health Syst Pharm; 2013 Jan; 70(1):8-10. PubMed ID: 23261891
[No Abstract] [Full Text] [Related]
16. Regulation of compounding by the food and drug administration: a tale of 2 circuits.
Williams KG
J Pharm Pract; 2010 Oct; 23(5):502-6. PubMed ID: 21507854
[TBL] [Abstract][Full Text] [Related]
17. Compounding pharmacies: who is in charge?
Pergolizzi JV; Labhsetwar S; LeQuang JA
Pain Pract; 2013 Mar; 13(3):253-7. PubMed ID: 23350709
[TBL] [Abstract][Full Text] [Related]
18. Compounding practices in Iran.
Goodarzi N; Niknam S; Akbarzadeh T; Gholami K
Int J Pharm Compd; 2014; 18(2):112-6. PubMed ID: 24881113
[TBL] [Abstract][Full Text] [Related]
19. Déjà vu all over again!
Allen LV
Int J Pharm Compd; 2014; 18(3):180. PubMed ID: 25306763
[No Abstract] [Full Text] [Related]
20. Update on medical and regulatory issues pertaining to compounded and FDA-approved drugs, including hormone therapy.
Pinkerton JV; Pickar JH
Menopause; 2016 Feb; 23(2):215-23. PubMed ID: 26418479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
